IL-6 activated the JAK2/p-STAT3 pathway in NSCLC cells, which exerts a synergistic effect with ALKBH5, thus maintaining an immunosuppressive microenvironment that drives tumorigenesis. The gene discussed is ALKBH5; the disease is non-small cell lung carcinoma.